- MS-DRGs are grouped by "Medical Service" to provide a meaningful way of summarizing utilization data.
- MS-DRGs are based on FY 2010 regulations.
| MS-DRG | MS-DRG Description |
|---|---|
| 009 | Bone marrow transplant |
| 054 | Nervous system neoplasms w MCC |
| 055 | Nervous system neoplasms w/o MCC |
| 146 | Ear, nose, mouth & throat malignancy w MCC |
| 147 | Ear, nose, mouth & throat malignancy w CC |
| 148 | Ear, nose, mouth & throat malignancy w/o CC/MCC |
| 180 | Respiratory neoplasms w MCC |
| 181 | Respiratory neoplasms w CC |
| 182 | Respiratory neoplasms w/o CC/MCC |
| 374 | Digestive malignancy w MCC |
| 375 | Digestive malignancy w CC |
| 376 | Digestive malignancy w/o CC/MCC |
| 435 | Malignancy of hepatobiliary system or pancreas w MCC |
| 436 | Malignancy of hepatobiliary system or pancreas w CC |
| 437 | Malignancy of hepatobiliary system or pancreas w/o CC/MCC |
| 597 | Malignant breast disorders w MCC |
| 598 | Malignant breast disorders w CC |
| 599 | Malignant breast disorders w/o CC/MCC |
| 686 | Kidney & urinary tract neoplasms w MCC |
| 687 | Kidney & urinary tract neoplasms w CC |
| 688 | Kidney & urinary tract neoplasms w/o CC/MCC |
| 722 | Malignancy, male reproductive system w MCC |
| 723 | Malignancy, male reproductive system w CC |
| 724 | Malignancy, male reproductive system w/o CC/MCC |
| 754 | Malignancy, female reproductive system w MCC |
| 755 | Malignancy, female reproductive system w CC |
| 756 | Malignancy, female reproductive system w/o CC/MCC |
| 834 | Acute leukemia w/o major O.R. procedure w MCC |
| 835 | Acute leukemia w/o major O.R. procedure w CC |
| 836 | Acute leukemia w/o major O.R. procedure w/o CC/MCC |
| 837 | Chemo w acute leukemia as sdx or w high dose chemo agent w MCC |
| 838 | Chemo w acute leukemia as sdx w CC or high dose chemo agent |
| 839 | Chemo w acute leukemia as sdx w/o CC/MCC |
| 840 | Lymphoma & non-acute leukemia w MCC |
| 841 | Lymphoma & non-acute leukemia w CC |
| 842 | Lymphoma & non-acute leukemia w/o CC/MCC |
| 843 | Other myeloprolif dis or poorly diff neopl diag w MCC |
| 844 | Other myeloprolif dis or poorly diff neopl diag w CC |
| 845 | Other myeloprolif dis or poorly diff neopl diag w/o CC/MCC |
| 846 | Chemotherapy w/o acute leukemia as secondary diagnosis w MCC |
| 847 | Chemotherapy w/o acute leukemia as secondary diagnosis w CC |
| 848 | Chemotherapy w/o acute leukemia as secondary diagnosis w/o CC/MCC |
| 849 | Radiotherapy |